GREGoRi Innovation Projects (U01 Clinical Trial Optional)
The Genomics Research to Elucidate the Genetics of Rare Diseases:innovation (GREGoRi) initiative seeks to accelerate a paradigm shift in rare disease diagnosis by reimagining the tools, molecular technologies and analytical approaches used to identify the causal gene(s) and/or variant(s) underlying rare genetic disorders. Offered by National Institutes of Health; awards $3 – $500K; applications due October 30, 2026.
Key Facts
- Funder
- National Institutes of Health
- Award amount
- $3 – $500K
- Deadline
- October 30, 2026
- Geography
- United States
- Categories
- Research
- Status
- Open
About This Grant
The Genomics Research to Elucidate the Genetics of Rare Diseases:innovation (GREGoRi) initiative seeks to accelerate a paradigm shift in rare disease diagnosis by reimagining the tools, molecular technologies and analytical approaches used to identify the causal gene(s) and/or variant(s) underlying rare genetic disorders. This Notice of Funding Opportunity is intended to stimulate the development and testing of highly innovative experimental or computational approaches for rare disease...
Full requirements and application instructions: official listing.
Similar Open Grants
Research Centers in Minority Institutions (RCMI) Coordinating Center (U24 - Clinical Trial Optional)
National Institutes of Health
Single Source: Post-Stroke Vascular Contributions to Cognitive Impairment and Dementia (VCID) in the United States (U19 - Clinical Trial Not Allowed)
National Institutes of Health
Validation Center for Precision Medicine with AI: Integrating Imaging with Multimodal Data (PRIMED-AI) (U54 Clinical Trials Not Allowed)
National Institutes of Health
Logistics Center for Precision Medicine with AI: Integrating Imaging with Multimodal Data (PRIMED-AI) (U24 Clinical Trials Not Allowed)
National Institutes of Health
Development and Testing of a Multi-use Frameworks Playbook for Precision Medicine with AI: Integrating Imaging with Multimodal Data (PRIMED-AI) (U01 Clinical Trial Not Allowed)
National Institutes of Health
Model-to-Clinic (M2C) for Precision Medicine with AI: Integrating Imaging with Multimodal Data (PRIMED-AI) (UG3/UH3, Clinical Trial Optional)
National Institutes of Health
GREGoRi Technology Integration Center (U01, Clinical Trials Optional)
National Institutes of Health
Large Health Services Research Demonstration and Dissemination Projects for Prevention of Healthcare-Associated Infections (R18)
Agency for Health Care Research and Quality
Large Research Projects for Prevention of Healthcare-Associated Infections (R01)
Agency for Health Care Research and Quality
Population Assessment of Tobacco and Health (PATH) Study Biospecimen Access (X01)
National Institutes of Health